Optimization of a pyrazoloquinolinone class of Chk1 kinase inhibitors

Edward J. Brnardic(United States Military Academy), Constantine Kreatsoulas(United States Military Academy), Xianzhi Mao(United States Military Academy), James C.H. Hardwick(Leiden University Medical Center), Robert B. Lobell(United States Military Academy), George D. Hartman(United States Military Academy), Vadim Dudkin(United States Military Academy), Keith Rickert(United States Military Academy), Steven M. Stirdivant(United States Military Academy), Kenneth L. Arrington(United States Military Academy), Laura Sepp‐Lorenzino(United States Military Academy), Justin T. Steen(United States Military Academy), Bob Drakas(United States Military Academy), Kelly Hamilton(United States Military Academy), Eileen S. Walsh(United States Military Academy), R. M. Garbaccio(Merck & Co., Inc., Rahway, NJ, USA (United States)), Carolyn A. Buser(United States Military Academy), Sanjeev Munshi(United States Military Academy), Youwei Yan(United States Military Academy), Stephen C. Beck(United States Military Academy), Mari Ikuta(United States Military Academy), Lawrence C. Kuo(United States Military Academy), Mark E. Fraley(United States Military Academy), Weikang Tao(Jiangsu Hengrui Medicine (China)), Edward S. Tasber(United States Military Academy)
Bioorganic & Medicinal Chemistry Letters
August 20, 2007
Cited by 44


Related Papers